In this review:
Melbourne Consensus Statement on Prostate Cancer Screening
Commercialisation of discovery research
Anxiety with active surveillance
Ertapenem prophylaxis for post-TRUS sepsis
Abiraterone acetate + prednisone for metastatic prostate cancer
Prostate cancer survival in Māori and non-Māori
Radium–223 safety and efficacy in prostate cancer
Multidisciplinary meetings for prostate cancer management
Supercastration for high-risk non-metastatic prostate cancer
Transrectal biopsies for incidentally diagnosed disease
Transperineal biopsy of the prostate
Please login below to download this issue (PDF)